Article Correctness Is Author's Responsibility: Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis

The article below may contain offensive and/or incorrect content.

Researchers evaluated clinical and magnetic resonance imaging data from patients with relapsing-remitting multiple sclerosis treated with alemtuzumab.